Tech & Pharma
A*STAR and KHIDI have signed a MOU to symbolize their growing bilateral cooperation in the field of biomedical sciences.
Strand Life Sciences is collaborating with El Camino Hospital to open a Strand Center for Genomics and Personalized Medicine in San Francisco, US.
IXICO plc and Beijing Union Medical have signed an MoU to jointly work on improving the diagnosis and treatment of dementia in China.
Takeda has announced clinical study results combining oral investigational MLN9708 with lenalidomide and dexamethasone, in patients with newly diagnosed multiple myeloma.
Teva and Takeda will jointly commercialize Teva’s glatiramer acetate formulation for the treatment of multiple sclerosis in Japan.
Helsinn Group, a Swiss pharmaceutical company that focuses on oncologic products, has opened a representative office in Beijing, China.
JHL Biotech and Selexis SA are collaborating to provide a seamless solution for the development and cGMP manufacturing of biologic drugs.
NovaBay Pharma has partnered with China Pioneer Pharma to market its products in China and 11 countries in Southeast Asia.
Shanghai Institute of Materia Medica and Crown BioScience, Inc. have agreed to jointly build a mouse clinical trial center in China.
A*STAR, GLOBALFOUNDRIES Singapore and MI have agreed to develop an R&D twin lab to advance MEMS technologies.